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ABSTRACT
Association Between Expanded Normal Weight Obesity and Insulin Resistance Among U.S.
Adults in the National Health and Nutrition Examination Survey
Keilah Elizabeth Martinez
Department of Exercise Sciences, BYU
Master of Science
OBEJCTIVE: The purpose of this investigation was to expand the evaluation of Normal Weight
Obesity (NWO) and its association with insulin resistance using a nationally representative
sample of U.S. adults.
METHODS: A cross-sectional study including 5,983 subjects was conducted. Body fat
percentage was assessed using dual energy X-ray absorptiometry (DXA). Expanded Normal
Weight Obesity (eNWO) categories (pairings of BMI and body fat percentage classifications)
were determined by standard cut-points for BMI and the gender specific median for body fat
percentage. Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) levels were used to
index insulin resistance.
RESULTS: Mean ± SE values were as follows: BMI: 27.9 ± 0.2 (women) and 27.8 ± 0.1 (men);
body fat percentage: 40.5 ± 0.2 (women) and 27.8 ± 0.2 (men); HOMA-IR: 2.04 ± 0.05 (women)
2.47 ± 0.09 (men). HOMA-IR differed systematically and in a dose-response fashion across all
levels of the eNWO categories (F = 291.3, P < 0.0001). As BMI levels increased, HOMA-IR
increased significantly and within each BMI category, higher levels of body fat were associated
significantly with higher levels of HOMA-IR.
CONCLUSION: Both high BMI and high body fat percentage are strongly related to insulin
resistance. In this study, insulin resistance increased incrementally according to BMI levels
primarily and body fat levels secondarily. Consequently, due to the costs associated with
precisely measuring body fat, and the accuracy of using BMI independently, we recommend that
BMI be used in its standard form to predict insulin resistance and not be supplemented with an
estimate of body fat.
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Introduction
Over the past several decades, the number of adults in America with excess body weight
has increased substantially.1 According to body mass index (BMI) data derived from the
National Health and Nutrition Examination Survey (NHANES), approximately 44% of adults
were overweight or obese in 1976-1980.2 The latest findings, published in 2014, indicate that the
prevalence has increased to 69% of adults,3 an increase of over 55%. This rising trend is not
without serious consequences.
Obesity is a significant risk factor for numerous medical conditions, including insulin
resistance and metabolic disease. In a recent paper, Lim et al. showed that obesity, whether
measured by BMI or body fat percentage, is highly correlated with insulin resistance, as indexed
by elevated homeostatic model assessment (HOMA-IR) levels.4 Additionally, BMI is a serious
risk factor for the development of type 2 diabetes, displaying a dose-response relationship.5
Research also shows that adults who have normal body weight, but excess body fat, are at
increased risk for developing metabolic syndrome and insulin resistance.6
Though frequently used to classify obesity, BMI does not measure adiposity. BMI is
calculated using only height and weight, not body composition.7 BMI often misclassifies those
with excess adiposity (high body fat percentage) as normal, or healthy.8 Though BMI has high
specificity for predicting high body fat percentage,9,10 several researchers have found that BMI
has low sensitivity for predicting body fat percentage.9-11
Many individuals assume that because they have a normal body weight, they are
metabolically healthy, and those who are overweight may assume that they are metabolically
unhealthy. Though commonly used, body weight, and particularly BMI, is not a high-quality
index of health status.
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Researchers have tried to remedy the problems associated with using BMI to index
overweight and obesity. As a result, the concept of Normal Weight Obesity (NWO) has emerged.
NWO, a condition in which individuals are classified as normal weight by BMI, but have excess
body fat (defined differently by various researchers), has not been researched extensively, but it
seems to be a good predictor of multiple health risks. In recent studies, NWO has been associated
with metabolic dysregulation,12 physical impairment,13 and cardiovascular mortality.14
NWO is a good predictor of insulin resistance. Research by Romero-Corral et al. shows
that adults with NWO have four times higher prevalence of metabolic syndrome compared to
their counterparts, and that insulin sensitivity tends to decrease as body fat percentage
increases.15 Other researchers have also shown that body fat percentage predicts insulin
resistance.16,17 Research by Madeira et al. indicates that those with NWO have six times greater
risk for metabolic syndrome than those without NWO.6 Additionally, adults with sarcopenic
obesity,18 low muscle mass and elevated body fat, also tend to have higher levels of metabolic
syndrome,19 insulin resistance,20,21 and several cardiovascular risk factors20 compared to their
counterparts.
Although promising, NWO is a limited index, including just one BMI category (normal
weight) and one body fat category (high body fat). There are many other possible BMI and body
fat combinations, such as underweight-low body fat (UW-L), underweight-high body fat (UWH), normal weight-low body fat (NW-L), normal weight-high body fat (NW-H), overweight-low
body fat (OW-L), overweight-high body fat (OW-H), obese-low body fat (OB-L), and obesehigh body fat (OB-H). In the present study, these categories are referred to as expanded normal
weight obesity, eNWO. To date, few if any studies have investigated multiple BMI and body fat
category pairings and their relationship with metabolic dysregulation. Moreover, when
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researchers have studied some BMI and body fat pairs, they have used bioelectrical
impedance14,19,22 or skinfolds6 to estimate body fat, as opposed to more precise and reliable
measurement tools.
The purpose of this investigation was to expand the evaluation of NWO and its
association with insulin resistance using a nationally representative sample of U.S. adults. A
secondary purpose was to overcome weaknesses of other obesity and metabolic dysregulation
research, particularly to assess body fat percentage using a high-quality measurement method,
dual energy x-ray absorptiometry (DXA), and to control for potentially confounding factors,
such as age, gender, race, smoking, and physical activity.
Methods
Study Design and Subject Selection
A cross sectional study was performed to examine the relationship between an expanded
version of NWO (eNWO) and insulin resistance in U.S. adults. Data on eNWO and insulin
resistance were obtained using BMI, body fat percentage, and HOMA-IR from the National
Health and Nutrition and Examination Surveys (1999-2006). NHANES is an extensive stratified
data set representative of the noninstitutionalized civilian population of the United States. More
details, including the datasets and methods, are available at
http://www.cdc.gov/nchs/nhanes.htm.
From the data collected by NHANES, subjects ages 20-84 years with information on age,
race/ethnicity, gender, BMI, body fat percentage, fasting blood glucose and insulin levels,
physical activity, and smoking status were included. The number of subjects who had both
insulin and glucose data (used to calculate HOMA-IR) was 12,561. Limiting the data to the age
range used in this study, 20-84, resulted in 8,331 subjects. By further narrowing the sample to
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nondiabetics and those not taking medication for diabetes, the sample was 7,249. Some subjects
had missing data for exposure or potentially confounding variables, or had invalid sample
weights, resulting in a total of 5,983 subjects. All measurement procedures below are taken from
the published guidelines and procedures used by the National Health and Nutrition Examination
Survey.23-27
Body Measurements
Weight was taken using a Toledo digital scale while the subject was wearing only
underwear, a disposable paper gown, and foam slippers. The participant was instructed to stand
still in the center of the scale, hands at side, and looking straight ahead. If the subject weighed
more than 440 pounds, two scales were used and the readings from each scale were added
together.23
Standing height was measured with a fixed stadiometer with a moveable headboard. The
subject was required to remove hair ornaments, jewelry, buns, braids, and corn rolls from the top
of the head. The subject was instructed to stand on the floor with the heels touching and toes
pointing out at about a 60 degree angle while making sure both feet were flat on the floor. The
heels, buttocks, shoulder blades, and back of head were to touch the vertical backboard if
possible. The head was aligned in the Frankfort horizontal plane, defined as the line from the ear
canal to the lower border of the orbit of the eye, parallel to the floor and perpendicular to the
backboard. Then the headboard was lowered to the top of the head of the participant with the
participant standing as tall as possible while taking a deep breath. The headboard was pressed
firmly to compress the hair.23
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Body Mass Index (BMI)
BMI is a commonly used measure of obesity. BMI is calculated using the following
formula: weight (kg) divided by height in meters squared.24 Underweight is defined as having a
BMI <18.5, normal weight is defined as having a BMI between 18.5 and 24.9, overweight
includes BMIs from 25.0-29.9, and obesity includes those with a BMI of 30.0 or higher.24
Body Composition
Body fat percentage using DXA was a measured variable in the NHANES 1999-2006
surveys only. DXA scans were performed in the mobile examination center. Pregnant females
were not scanned. The whole-body DXA scan used a Hologic QDR 4500A fan-beam
densitometer (Hologic, Inc., Bedford, MA). Hologic DOS software was used to acquire the scans
while scanning in fast mode.23
DXA scans provide total body fat and lean muscle mass measurements. Sampled
participants taller than 6’5” had to be excluded due to table and room size limitations. If the
participant weighed more than 300 pounds, he/she was excluded from the DXA scan due to the
weight limitation of the table.23 Due to these exclusions for large body sizes, missing and invalid
DXA data were not missing at random, leading the NHANES analysts to perform multiple
imputations to fill in the data for analysis. Details of the multiple imputations are described
elsewhere.28,29
All metal objects such as jewelry, belts, and snaps were removed from the body (small
rings that would not come off were acceptable).23
The entire body of the sampled participant had to be within the scan border, including the
head. Double-sided Velcro was used to help feet remain in an internally rotated position. The
participant reclined flat and straight on the table without a pillow with their arms at their sides,

5

palms down. If the subject could not lay flat with head slightly supported, he/she was excluded
from the exam.23
Insulin Resistance
Insulin resistance was indexed using HOMA-IR (fasting insulin (μU/mL) × fasting
glucose (mg/dL)/405). Fasting insulin and fasting glucose data were obtained through the
NHANES measurements of diabetes profiles.25 Diabetic individuals (defined as having a fasting
blood glucose of ≥126 mg/dL, being told by a physician that one is diabetic, or using insulin or
using an oral medication for diabetes) were not included in the study because of their extreme
HOMA-IR scores when not taking medication and their regulated values when taking
medication.
Subjects assigned to morning sessions were asked to fast for 9 hours. Blood was collected
by a certified phlebotomist. Before collection, the phlebotomist administered the fasting
questionnaire, which included questions pertaining to the last time the subject ate or drank
anything except plain water. Subjects were asked specifically about coffee, tea, alcohol, gum,
breath mints, cough drops, antacids, supplements, and other items to ensure proper recall. A
blood sample of 89-92 ml was collected. Blood samples were not collected from hemophiliacs,
participants who received chemotherapy in the last 4 weeks, or those with rashes, edema,
paralysis, wounds, burns, or scar tissue.25
Insulin specimens were collected as a serum without anticoagulants or preservatives.
Specimens were allowed to clot at room temperature for 15-30 minutes, then centrifuged at 1500
× g for 10 min, then transferred to a 2-mL cryogenic screw-top vial and frozen at -20 degrees C.
The specimens were sent in weekly batches in Styrofoam-insulated shipping containers with dry
ice to the University of Missouri Diabetes Diagnostic Laboratory via overnight courier. Upon
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receipt, the processing laboratory stored the specimens in a -70-degree C freezer until analyzed.
No analyses were performed on specimens that thawed. Jouan refrigerated centrifuge models
GR4-22 and K110 and a gamma counter were used.25
In the 1999-2000 and 2001-2002, insulin radioimmunoassay (RIA), a double-antibody
batch method was used to measure insulin levels. The measurements for the 1999-2000 and
2001-2002 data were conducted by the University of Missouri-Columbia.25
In the 2003-2004 data collection, the Tosoh AIA-PACK IRI, a two-site
immunoenzymometric assay, was used to assess fasting insulin levels.26 The 2003-2004
measurements were also conducted by the Diabetes Diagnostic Laboratory at the University of
Missouri-Columbia.
In the 2005-2006 data collection, the Merocodia Insulin ELISA, a two-site enzyme
immunoassay was used.27 The glucose and insulin measurements in 2005-2006 were conducted
by the Fairview Medical Center Laboratory at the University of Minnesota.
Because some of the insulin measurement procedures were changed after the 1999-2002
cycle, in order to allow all of the insulin data to be combined into one data set, a regression
equation was created by NHANES. Insulin data from 2003-2004 were used as the reference
group.26
Insulin2003-2004 = (1.0027 * insulin1999-2002) - 2.2934 (n = 245, r = 0.981).
Similarly, the 2005-2006 insulin data were converted so that it would equal the 20032004 data, using the following equation.27
Insulin2003-2004 = 1.0526 * Insulin2005-2006 – 1.5674 (n = 189, r = 0.9870)
Fasting glucose was measured using a specimen of 1.5 mL plasma with NaF as
preservative.25 Samples of whole blood in measurements of 3 to 5 mL were collected in a
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vacuum tube containing glycolytic inhibitors, potassium oxalate, and sodium fluoride and were
then immediately centrifuged at 1500 g for 10 min. Plasma was then transferred to a 2-mL
cryogenic screw-cap vial and frozen at -70 degrees C. Frozen plasma specimens were shipped
weekly in batches to the University of Missouri Diabetes Diagnostic Laboratory via overnight
courier.
In 1999-2004, the enzyme hexokinase method was used to catalyze the reaction between
glucose and adenosine triphosphatease to form glucose-6-phosphate and adenosine diphosphate,
using a rise in NADH concentration as a marker of glucose concentration.25
In 2005-2006, glucose concentrations were determined using a hexokinase strategy with a
sample blank correction. In order to combine the glucose data, NHANES created a regression
equation to convert the 2005-2006 glucose data so that it would be comparable to the data from
1999-2004.27
Glucose1999-2004 = 0.9835* Glucose2005-2006, n = 92, r = 0.9993
Expanded Normal Weight Obesity (eNWO)
In order to study the relationship between eNWO and insulin resistance, we formed
pairings of BMI and body fat percentage. Underweight-low body fat (UW-L) was defined as
having a BMI <18.5 kg/m2 and a body fat percentage below the overall gender-specific median.
Underweight-high body fat (UW-H) was defined as having a BMI <18.5 kg/m2 and a body fat
percentage above the gender-specific median. Normal weight-low body fat (NW-L) was defined
as having a normal BMI (18.5-24.9 kg/m2) and a body fat percentage below the gender-specific
median. Normal weight-high body fat (NW-H) was defined as subjects having a normal BMI
(18.5-24.9 kg/m2) and a body fat above the gender-specific median. Overweight-low body fat
(OW-L) was defined as having a BMI of 25-29.9 kg/m2 and a body fat percentage below the
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gender-specific median. Overweight-high body fat (OW-H) was defined as having a BMI of 2529.9 kg/m2 and a body fat percentage above the gender-specific median. Obese-low body fat
(OB-L) was defined as having a BMI 30 kg/m2 and a body fat percentage below the genderspecific median. Obese-high body fat (OB-H) was defined as having a BMI 30 kg/m2 and a
high body fat percentage above the gender-specific median.
Covariates
The study controlled for differences in age, gender, race, cigarette smoking, and physical
activity. NHANES uses the following race/ethnicity categories: Non-Hispanic White, NonHispanic Black, Mexican American, Other Race, including Multi-Racial, and Other Hispanic.
Research shows that various demographic factors affect BMI and body composition, including
age,30 gender,30 and race/ethnicity.31
Cigarette smoking was indexed using pack-years. The number of cigarettes smoked per
day and the number of years the person has smoked was multiplied and then divided by 20,
resulting in a continuous variable, pack years.32 Research shows that cessation of smoking is
associated with weight gain.33 Research also indicates that smokers weigh less than neversmokers.34 Additional research shows that smokers tend to be leaner35 and lighter36 than
nonsmokers. Smokers also tend to have a higher risk of developing insulin resistance and
hyperinsulinemia,37 as well as an increased risk for metabolic syndrome.38
NHANES assesses participation in moderate and vigorous physical activity by employing
two separate questions.32 Moderate activity was assessed by asking subjects whether or not they
participated in moderate physical activity for at least 10 minutes over the last 30 days. Moderate
activity was described as causing only light sweating or a slight to moderate increase in
breathing or heart rate, as used in other research.39,40 Examples included brisk walking, bicycling
9

for pleasure, golf, and dancing. Involvement in vigorous activity was measured similarly, but
vigorous activity was described as causing heavy sweating or large increases in breathing or
heart rate.39 Examples included running, lap swimming, aerobics classes, or fast bicycling.
Several investigations indicate that participation in moderate and/or vigorous physical activity
are predictive of lower levels of body weight and fat41,42 and lower risk of insulin resistance.43
Data Analysis
Results derived from NHANES research are special and unique because they can be
generalized to the U.S. noninstitutionalized civilian population. This is because of the use of
sample weights. According to NHANES, a sample weight is assigned to each participant. It is a
measure of the number of people in the population represented by that sample person in
NHANES, reflecting the unequal probability of selection, nonresponse adjustment, and
adjustment to independent population controls. When unequal selection probability is applied,
the sample weights can be used to produce an unbiased national estimate.
In the present study, descriptive data, including frequencies for categorical variables and
means ± standard errors for continuous variables, were reported. Each descriptive value included
adjustments based on the complex sampling design of NHANES by incorporating strata and
primary sampling unit (PSU) indicators, as well as sample weights for the subsample of fasting
participants used in the current study. Proc SurveyMeans was employed to generate weighted
means that represent values for the U.S. population, and Proc SurveyFreq was used to calculate
weighted frequencies, which are also generalizable to the U.S. adult population.
The primary outcome variable of the current study was insulin resistance, indexed using
HOMA-IR. Individuals with fasting blood glucose levels > 126 mg/dL, signifying diabetes, and
participants who reported being told by their physician that they had diabetes, were removed
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from the data set because medications affecting insulin and glucose would significantly affect
HOMA-IR levels. Similarly, individuals reporting that they take insulin or other medications to
control their blood sugar levels were not included in the analyses.
Because HOMA-IR distributions deviated significantly from normality, HOMA-IR
values were transformed by natural logarithm prior to modeling. To aid interpretation of the
results, untransformed HOMA-IR values were reported in this study.
For the current study, the exposure variable was a version of normal weight obesity
expanded to include all categories of BMI (eNWO), which has not been investigated in past
studies. The typical BMI categories (underweight, normal weight, overweight, and obese) were
used along with two categories based on body fat percentage (low body fat and high body fat).
The eNWO was a categorical variable reflecting each possible pairing between the four BMI
categories and the two categories of body fat. In total, there were eight eNWO categories, as
follows: underweight-low body fat, underweight-high body fat, normal weight-low body fat,
normal weight-high body fat, overweight-low body fat, overweight-high body fat, obese-low
body fat, and obese-high body fat. Both underweight categories were combined into one general
underweight category because the number of subjects in each was extremely low.
The extent to which mean HOMA-IR values differed across the categories of eNWO was
determined using linear regression analysis and the Proc SurveyReg procedure. Estimates from
each regression model were based on the complex, multistage, probability sampling process of
NHANES and incorporated the strata, primary sampling units, and sample weights for the fasting
subsample used in the present study. To test the hypothesis that the association between eNWO
and insulin resistance is partially mediated by differences in age, gender, and race, these factors
were controlled statistically using partial correlation. The potential confounding effects of
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cigarette smoking, moderate physical activity, and vigorous physical activity were also tested
using partial correlation and the Proc SurveyReg procedure. Adjusted means were calculated
using the least-squares means procedure.
All P-values were two-sided and statistical significance was accepted when alpha was <
0.05. The statistical analyses were computed using SAS Version 9.4 (SAS Institute, Inc., Cary,
NC).
Results
Descriptive information about the sample of 5,983 participants is displayed in Table 1. In
brief, more participants fit the normal weight-low body fat category than any other, although
prevalence within the obese-high body fat group was similar. Overall, nearly two-thirds of the
sample was overweight or obese, according to typical BMI cut-points. Additionally, 55% of the
sample reported that they did not get at least 10 minutes of moderate-intensity physical activity
in the past 30 days and over 60% reported that they did not get 10 minutes of vigorous-intensity
activity in the past 30 days.
Mean BMI (± SE) was 27.9 ± 0.2 kg/m2 for women and 27.8 ± 0.1 kg/m2 for men,
whereas average body fat percentage was 40.5 ± 0.2 and 27.8 ± 0.2 for women and men,
respectively. Mean HOMA-IR was 2.04 ± 0.05 for women and 2.47 ± 0.09 for men.
As shown in Table 2, with the BMI and body fat measures combined, HOMA-IR levels
differed systematically and in a dose-response fashion across all seven of the eNWO categories
(F = 291.3, P < 0.0001). As BMI levels increased, HOMA-IR increased significantly, and within
each BMI category, higher levels of body fat were associated significantly with higher levels of
HOMA-IR. Adjusting for differences in the demographic covariates, specifically age, gender,
race, and year of assessment, adjusted the relationship between eNWO and HOMA-IR slightly
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(F = 286.2, P < 0.0001). However, controlling for differences in the lifestyle covariates, in
addition to the demographic variables, strengthened the association between eNWO and HOMAIR (F = 340.9, P < 0.0001).
HOMA-IR differences between the high- and low-body-fat categories within each BMI
level were meaningful. For example, within the normal weight BMI category, the HOMA-IR
mean for the high body fat group was approximately 45% higher than it was for those in the low
body fat category.
As shown in Table 3, with subjects divided into BMI categories based on sex-specific
quintiles, HOMA-IR differed significantly across the five BMI groups (BMI5) with no variables
controlled (F = 448.5, P < 0.0001). With participants divided into body-fat-percentage categories
based on sex-specific quintiles (BF%5) and no variables controlled, the relationship with
HOMA-IR was similar (F = 451.6, P < 0.0001), as displayed in Table 4. Adjusting for
differences in all of the demographic and lifestyle covariates resulted in stronger associations
between HOMA-IR and BMI5 (F = 464.4, P < 0.0001) and BF%5 (F = 511.3, P < 0.0001), as
shown in Table 3 and Table 4, respectively. The relationship between BMI5 and HOMA-IR was
weakened substantially when all of the covariates and also BF%5 were controlled statistically (F
= 141.9, P < 0.0001), as shown in Table 3. However, the association between BF%5 and
HOMA-IR was weakened to a greater extent after adjusting for all of the covariates and also
BMI5 (F = 68.8, P < 0.0001), as shown in Table 4.
The relationship between BMI and body fat percentage was moderate (R2 = 0.325, F =
2194.4, P < 0.0001) with both variables treated as continuous variables. With BMI and body fat
percentage divided into sex-specific quintiles, the association was also significant (Wald ChiSquare = 1411.0, F = 88.2, P < 0.0001). Agreement among quintiles was modest. There was 67%
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agreement between quintile 1 for BMI5 and quintile 1 for BF%5. For quintile 5, agreement was
similar (66%) for BMI5 and BF%5. However, for quintile 2, agreement was 37% and for quintile
3, agreement was 33%. For quintile 4, agreement was 38%.
Discussion
Obesity is a major risk factor for numerous medical conditions, including insulin
resistance.4 Further, an elevated BMI significantly increases risk for developing type 2 diabetes.5
Some investigations have shown that adults with normal BMIs but excess body fat, normal
weight obesity (NWO), are also at increased risk for developing metabolic syndrome and insulin
resistance.6 The purpose of the present study was to expand the concept of NWO (eNWO) to
include all BMI categories, along with a precise measure of body fat, and investigate the
relationship between eNWO and insulin resistance.
According to the results, there appears to be an undeviating dose-response relationship
for insulin resistance across each of the seven eNWO categories. Specifically, with each BMI
category divided into low- and high-body-fat groups, HOMA-IR varies according to body fat
levels within each BMI category. This pattern remains consistent across the entire eNWO
spectrum, without exception, and each HOMA-IR mean differs significantly from each other
mean across every eNWO category (Table 2).
If body fat plays a more important role than BMI in insulin resistance, as suggested by
Gomez-Ambrosi,44 one would expect individuals with low body fat to have lower HOMA-IR
levels than those in a neighboring lower BMI category with high body fat. For example, if body
fat was key, then logic would suggest that participants in the overweight-low body fat category
would tend to have lower HOMA-IR levels than those in the normal weight-high body fat
category. However, this was not supported by the present study. Instead, HOMA-IR moved
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incrementally according to BMI levels primarily and body fat levels secondarily. Specifically,
individuals in the overweight-low body fat category had significantly higher HOMA-IR levels
than those in the normal weight-high body fat category, and this pattern persisted across all of
the eNWO categories.
Testing for differences in HOMA-IR across the gender-specific BMI (Table 3) and bodyfat-percentage (Table 4) quintiles separately showed that the two body composition indexes have
similar independent associations with HOMA-IR. However, after adjusting for differences in the
covariates and BMI5 (BMI quintile), the relationship between body fat percentage quintile
(BF%5) and HOMA-IR was attenuated more than when the covariates and BF%5 were
controlled and the association between BMI5 and HOMA-IR was tested. Apparently, the
relationship between BMI and HOMA-IR is much stronger after adjusting for body fat
differences than the association between body fat and HOMA-IR with BMI controlled.
Specifically, with no variables controlled statistically, mean HOMA-IR for the fifth quintile of
BMI was approximately 4x greater than the mean for the first BMI quintile. However, after
adjusting for all of the covariates and BF%5, mean HOMA-IR for the fifth BMI quintile was
2.7x greater than the first BMI quintile. On the other hand, with no variables controlled, mean
HOMA-IR for the fifth quintile of BF% was approximately 4x greater than the first quintile of
BF%. However, after adjusting for all of the covariates and BMI5, mean HOMA-IR for the fifth
BF% quintile was only 1.6x greater than the HOMA-IR mean of the first BF% quintile.
Although both BMI and body fat percentage appear to play important roles in insulin
resistance, NHANES data suggests that the contribution of BMI is greater than the contribution
of body fat percentage. Therefore, given the costs of time, training, and equipment associated
with measuring body fat to supplement BMI, and also the fact that BMI results remain the same
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whether or not body fat findings are included, it seems that for predicting HOMA-IR, the better
choice is to differentiate adults according to BMI and not include a measure of body fat
percentage.
To date, a limited number of studies have investigated the relationship between NWO
and insulin resistance. However, few have used a reliable measure of body fat, such as DXA
scans, and none have examined the spectrum of categories included in eNWO. The studies which
investigated only the NWO category compared to a non-NWO category had similar results to the
present study in that individuals with normal weight and high body fat had higher rates of
metabolic dysfunction than those with normal weight and low body fat. For example, Madeira et
al. investigated NWO and its relationship with insulin resistance and found that the presence of
NWO, measured by skinfolds, was correlated with low insulin sensitivity compared to those of a
normal weight without high body fat.6 Additionally, Romero-Corral et al. studied the relationship
between NWO and metabolic syndrome, and found that NWO, when measured by bioelectrical
impedance, was associated with four times the prevalence of metabolic syndrome compared to
those in a normal weight-low body fat group.15 Batsis found that NWO, indexed using
bioelectrical impedance, predicted prevalence of higher insulin resistance when using tertiles, but
not cut-points, for body fat.14 In another investigation which used air displacement
plethysmography to determine body fat percentage, findings showed that NWO predicted higher
HOMA-IR levels.16 Lastly, only one other study has used DXA to measure body fat, and this
investigation found that NWO was associated with higher insulin resistance, but, like the others,
it did not look at categories beyond normal weight-high body fat and normal weight-low body
fat.17
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It appears that the present study is consistent with the findings of previous research
conducted to compare insulin resistance among adults with normal weight and high body fat to
those with normal weight and low body fat. However, no other investigations have evaluated
normal weight obesity in its expanded form.
Potential Mechanisms
Currently, there is little known concerning the mechanisms associated with NWO as it
relates to insulin resistance.45 However, there are a few potential mechanisms. First, in general, it
appears that women with NWO generally tend to have higher levels of cardiovascular risk
factors, including blood pressure, lipids, and hyperglycemia compared to lean women.45
Additionally, plasma leptin concentrations are correlated with BMI and body fat levels.45
Research shows that women with NWO have higher leptin levels than lean women, but lower
levels than women with obesity.45 Additionally, it is possible that absolute amount of fat mass,
rather than body fat percentage, plays a role in the relationship with HOMA-IR.
Another possible mechanism, as discussed by Jean et al., is that metabolically obese
normal-weight individuals may tend to be more sedentary or have increased carbohydrate intake
compared to their counterparts, which could lead to increased fat cell size and insulin secretion.46
Further, the amount of adipose tissue in the body significantly affects hormone levels in the
body47 and various hormones released by the adipose tissue play an important role in metabolic
complications.48 Additionally, adipose cell size is predictive of metabolic dysregulation.49,50
Energy intake may be a moderating factor,51 affecting the relationship between insulin
resistance and eNWO. Insulin resistance denotes a physiologic adaptation that may restrict the
further storing of fat.51 Some studies indicate that insulin resistance may protect against weight
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gain when body weight levels are extreme, but other studies show conflicting results.51
Limitations and Strengths
The present study had some limitations. Due to the cross-sectional nature of the study,
causality or directionality of the relationship between insulin resistance, BMI, and body fat
percentage could not be determined. It is possible that a high BMI or high body fat percentage
may cause an increase in insulin resistance, or insulin resistance may lead to a change in BMI or
body fat percentage. Moreover, the present study controlled for several potential confounding
variables, including age, gender, race, physical activity, and smoking, but there is always a
possibility that an unknown lurking variable, not controlled in this investigation, was responsible
for the relationship between eNWO and insulin resistance. Accuracy of self-reported variables
was another potential limitation. Assessment of physical activity and smoking habits were both
self-reported, and therefore may contain error due to misreporting.
A strength of the present study was its large sample size representing noninstitutionalized
civilians in the United States. As the sample represents virtually all of the United States adult
population, the results are much more generalizable than previous studies investigating NWO.
Another strength was the use of DXA, a reliable and precise measure of body fat. Previous
research has employed skinfolds, bioelectrical impedance, and other methods lacking the
precision and reliability of DXA. Lastly, the present study expanded NWO, allowing the effect
of body fat to be studied across each level of BMI. The concept of NWO has never been
expanded before.
In conclusion, both high BMI and high body fat percentage are strongly related to insulin
resistance. However, according to the present study based on NHANES data, insulin resistance
increases incrementally according to BMI levels primarily and body fat levels secondarily.
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Consequently, due to the costs associated with precisely measuring body fat and the accuracy of
using BMI independently, we recommend that BMI be used in its standard form to predict
insulin resistance and not be supplemented with an estimate of body fat.
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Table 1 Descriptive characteristics of the sample and mean HOMA-IR for each category (n =
5,983)
Weighted Mean
Categorical Variable
N
%
HOMA
SE
F
P
eNWO
291.3
<0.0001
Underweight
94
1.9
0.8a
0.07
Normal weight-low body fat
1624
30.1
1.1b
0.02
c
Normal weight-high body fat
288
4.5
1.6
0.08
Overweight-low body fat
927
15.9
1.9d
0.05
Overweight-high body fat
1221
18.3
2.2e
0.07
f
Obese-low body fat
141
2.1
3.2
0.28
Obese-high body fat
1688
27.2
3.9g
0.14
Gender
34.2
<0.0001
Men
2939
50.8
2.5
0.09
Women
3044
49.2
2.0
0.05
Race
15.0
<0.0001
a
Non-Hispanic White
2468
55.8
2.2
0.09
Non-Hispanic Black
847
7.9
2.5b,d
0.07
c,d
Mexican American
1072
5.5
2.6
0.08
Other Race
1401
26.8
2.3a
0.08
Other Hispanic
195
3.9
2.4d
0.23
Year of Assessment
4.0
0.0114
1999-2000
1489
23.1
2.2a,b
0.08
2001-2002
1679
26.9
2.1b,c
0.06
2003-2004
1540
26.0
2.5a
0.16
c
2005-2006
1275
23.9
2.3
0.09
Moderate Physical Activity
14.2
0.0004
Yes
3055
45.0
2.2
0.07
No
2928
55.0
2.4
0.06
Vigorous Physical Activity
30.12
<0.0001
Yes
2000
38.2
2.0
0.06
No
3983
61.8
2.4
0.07
eNWO = expanded normal weight obesity category
Low body fat is defined as below the overall gender-specific median, and high body fat is
defined as above the overall gender-specific median.
In the column titled Weighted %, summing the values may not equal 100% due to rounding.
The F values reflect mean HOMA-IR differences across each categorical variable without
adjusting for any covariates.
For each variable, means with the same superscript letter in the Mean HOMA column indicate
that the means are not significantly different (P > 0.05).
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Table 2 Mean differences in HOMA-IR across the expanded normal weight obesity (eNWO) categories, adjusted for covariates.
Expanded Normal Weight Obesity (eNWO)
Covariates
None
Demographics*
Demographics
and Lifestyle†

UW
Mean ± SE
0.8 ± 0.07a
0.9 ± 0.09a

NW-L
Mean ± SE
1.1 ± 0.02b
1.2 ± 0.05b

NW-H
Mean ± SE
1.6 ± 0.08c
1.7 ± 0.08c

OW-L
Mean ± SE
1.9 ± 0.05d
1.8 ± 0.07d

OW-H
Mean ± SE
2.2 ± 0.07e
2.3 ± 0.08e

OB-L
Mean ± SE
3.2 ± 0.28f
3.2 ± 0.28f

OB-H
Mean ± SE
3.9 ± 0.14g
4.0 ± 0.13g

F
291.3
286.2

P
<0.0001
<0.0001

0.9 ± 0.09a

1.1 ± 0.05b

1.6 ± 0.09c

1.8 ± 0.07d

2.2 ± 0.09e

3.2 ± 029f

3.9 ± 0.12g

340.9

<0.0001

UW = underweight
NW-L = normal weight-low body fat
NW-H = normal weight-high body fat
OW-L = overweight-low body fat
OW-H = overweight-high body fat
OB-L = obese-low body fat
OB-H = obese-high body fat
Each mean on the same row is significantly different from each other mean (P < 0.05).
*Demographic covariates included: age, gender, race, and year of assessment.
†
Lifestyle covariates included: moderate physical activity, vigorous physical activity, and smoking.
Means on the same row have been adjusted for differences in the covariates listed in the first column.
Means ± SE on the same row with different superscript letters are significantly different from each other.
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Table 3 Mean HOMA-IR values across BMI quintiles without and with control of potential confounders
BMI Quintiles§
Variable
Quintile 1
Quintile 2
Quintile 3
Quintile 4
Quintile 5
controlled
Mean ± SE
Mean ± SE
Mean ± SE
Mean ± SE
Mean ± SE
a
b
c
d
None
1.04 ± 0.03
1.36 ± 0.03
1.94 ± 0.05
2.60 ± 0.08
4.31 ± 0.17e
Demographics*
1.10 ± 0.06a
1.41 ± 0.05b
1.99 ± 0.06c
2.65 ± 0.10d
4.37 ± 0.16e
Demographics
and Lifestyle†
1.11 ± 0.05a
1.42 ± 0.05b
2.01 ± 0.06c
2.65 ± 0.10d
4.35 ± 0.16e
Demographics,
Lifestyle, BF%5
1.48 ± 0.06a
1.59 ± 0.05b
2.02 ± 0.06c
2.50 ± 0.10d
3.95 ± 0.14e

F
448.54
431.10

P
<0.0001
<0.0001

464.39

<0.0001

141.88

<0.0001

§

Gender specific quintile
*Demographic covariates included: age, gender, race, and year of assessment.
†
Lifestyle covariates included: moderate physical activity, vigorous physical activity, and smoking.
Means on the same row have been adjusted for differences in the covariates listed in the first column.
Each mean on the same row is significantly different from each other mean (P < 0.05).
BF%5 represents the variable, body fat percentage, divided into quintiles.
Means ± SE on the same row with different superscript letters are significantly different from each other.
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Table 4 Mean HOMA-IR values across body fat percentage quintiles without and with control of potential confounders
Body Fat Percentage Quintiles§
Variable
Quintile 1
Quintile 2
Quintile 3
Quintile 4
Quintile 5
controlled
Mean ± SE
Mean ± SE
Mean ± SE
Mean ± SE
Mean ± SE
F
a
b
c
d
e
None
0.99 ± 0.03
1.55 ± 0.5
2.16 ± 0.07
2.60 ± 0.07
3.92 ± 0.17
451.61
Demographics*
0.98 ± 0.45a
1.59 ± 0.07b
2.24 ± 0.08c
2.72 ± 0.08d
4.06 ± 0.15e
448.21
Demographics
and Lifestyle†
1.01 ± 0.05a
1.60 ± 0.07b
2.25 ± 0.08c
2.71 ± 0.08d
4.04 ± 0.15e
511.33
Demographics,
Lifestyle, BMI5
1.80 ± 0.07a
2.10 ± 0.08b
2.38 ± 0.08c
2.34 ± 0.07c
2.91 ± 0.11d
68.83

P
<0.0001
<0.0001
<0.0001
<0.0001

§

Gender specific quintile
*Demographic covariates included: age, gender, race, and year of assessment.
†
Lifestyle covariates included: moderate physical activity, vigorous physical activity, and smoking.
Means on the same row have been adjusted for differences in the covariates listed in the first column.
Each mean on the same row is significantly different from each other mean (P < 0.05).
BMI5 represents the variable, body mass index, divided into quintiles.
Mean ± SE on the same row with different superscript letters are significantly different from each other.
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